DexCom

YTD

ALL

Trade DexCom 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About DXCM

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE.

CEO

Jacob S. Leach

CEOJacob S. Leach

Employees

11,100

Employees11,100

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1999

Founded1999

Employees

11,100

Employees11,100

DXCM Key Statistics

Market cap

24.09B

Market cap24.09B

Price-Earnings ratio

30.93

Price-Earnings ratio30.93

Dividend yield

—

Dividend yield—

Average volume

4.60M

Average volume4.60M

High today

$65.00

High today$65.00

Low today

$62.41

Low today$62.41

Open price

$65.00

Open price$65.00

Volume

4.36M

Volume4.36M

52 Week high

$89.98

52 Week high$89.98

52 Week low

$54.11

52 Week low$54.11

Stock Snapshot

As of today, DexCom(DXCM) shares are valued at $63.35. The company's market cap stands at 24.09B, with a P/E ratio of 30.93.

As of 2026-04-22, DexCom(DXCM) stock has fluctuated between $62.41 and $65.00. The current price stands at $63.35, placing the stock +1.5% above today's low and -2.5% off the high.

The DexCom(DXCM)'s current trading volume is 4.36M, compared to an average daily volume of 4.6M.

In the last year, DexCom(DXCM) shares hit a 52-week high of $89.98 and a 52-week low of $54.11.

DXCM News

Simply Wall St 16h

DexCom’s Q1 2026 Earnings Might Change The Case For Investing In DexCom

DexCom, the San Diego-based continuous glucose monitoring company, released its fiscal first-quarter 2026 results on April 30, reporting diluted earnings of US$...

Nasdaq 1d

Better Medical Device Stock Right Now: Abbott Laboratories vs. Dexcom

Key Points Abbott Laboratories and Dexcom are the biggest players in the market for continuous glucose monitoring devices. Abbott has a vast lineup of product...

Simply Wall St 5d

A Look At DexCom Valuation After Recent Share Weakness And Growth Outlook

Advertisement Recent share performance and business snapshot DexCom (DXCM) has drawn attention after recent share weakness, with the stock down about 12% over...

Analyst ratings

84%

of 31 ratings

Buy

83.9%

Hold

12.9%

Sell

3.2%

People also own

Based on the portfolios of people who own DXCM. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.